| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
15,883 |
14,207 |
$1.33M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,886 |
26,908 |
$1.12M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,137 |
10,094 |
$714K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,352 |
15,632 |
$399K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,803 |
5,772 |
$323K |
| 99205 |
Prolong outpt/office vis |
1,076 |
1,075 |
$85K |
| 99215 |
Prolong outpt/office vis |
1,203 |
1,133 |
$69K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,362 |
3,173 |
$59K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,778 |
1,737 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
749 |
749 |
$25K |
| 99401 |
|
6,861 |
6,646 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,955 |
3,777 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
830 |
824 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,749 |
1,727 |
$1K |
| 99072 |
|
757 |
721 |
$1K |
| 99051 |
|
302 |
289 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
786 |
771 |
$1K |
| 94760 |
|
226 |
216 |
$1K |
| 99000 |
|
2,926 |
2,886 |
$607.61 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,249 |
1,227 |
$573.76 |
| 81003 |
|
3,075 |
3,034 |
$556.43 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,015 |
931 |
$544.33 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
956 |
947 |
$307.86 |
| 69210 |
|
51 |
50 |
$300.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,075 |
1,069 |
$259.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
793 |
780 |
$220.04 |
| 87428 |
|
48 |
48 |
$200.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
409 |
407 |
$187.58 |
| 93000 |
|
56 |
56 |
$136.00 |
| 81025 |
|
88 |
88 |
$31.92 |
| 73630 |
|
15 |
14 |
$24.22 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
77 |
74 |
$17.24 |
| 81002 |
|
450 |
435 |
$10.67 |
| 86328 |
|
118 |
118 |
$0.00 |
| 73610 |
|
29 |
27 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
12 |
12 |
$0.00 |
| 82962 |
|
12 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
40 |
40 |
$0.00 |